Blueberries Medical Corp. (BBRRF)
OTCMKTS
· Delayed Price · Currency is USD
0.0105
+0.0014 (15.38%)
Apr 28, 2025, 1:36 PM EDT
Blueberries Medical Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 0.47 | 0.29 | 0.24 | 0.14 | 0.07 | Upgrade
|
| Revenue Growth (YoY) | 63.53% | 22.43% | 69.70% | 110.29% | - | Upgrade
|
| Cost of Revenue | 0.31 | 0.2 | 0.25 | 0.38 | 0 | Upgrade
|
| Gross Profit | 0.16 | 0.08 | -0.02 | -0.25 | 0.06 | Upgrade
|
| Selling, General & Admin | 0.94 | 1.29 | 1.36 | 0.67 | 2.55 | Upgrade
|
| Operating Expenses | 1.08 | 1.46 | 1.62 | 1.54 | 4.19 | Upgrade
|
| Operating Income | -0.91 | -1.38 | -1.64 | -1.79 | -4.12 | Upgrade
|
| Interest Expense | - | -0.26 | -0.36 | -0.27 | -0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.07 | 0.15 | -0.12 | -0.17 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0.02 | 0.51 | 0.38 | -0.65 | Upgrade
|
| EBT Excluding Unusual Items | -0.98 | -1.47 | -1.61 | -1.84 | -4.94 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.57 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.17 | 0.02 | 0.02 | - | - | Upgrade
|
| Asset Writedown | - | -0.18 | - | -2.82 | - | Upgrade
|
| Other Unusual Items | - | - | 0.13 | 0.09 | - | Upgrade
|
| Pretax Income | -1.15 | -1.64 | -1.47 | -5.15 | -4.94 | Upgrade
|
| Net Income | -1.15 | -1.64 | -1.47 | -5.15 | -4.94 | Upgrade
|
| Net Income to Common | -1.15 | -1.64 | -1.47 | -5.15 | -4.94 | Upgrade
|
| Shares Outstanding (Basic) | 399 | 219 | 169 | 149 | 124 | Upgrade
|
| Shares Outstanding (Diluted) | 399 | 219 | 169 | 149 | 124 | Upgrade
|
| Shares Change (YoY) | 81.95% | 29.85% | 13.73% | 19.83% | 13.78% | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.01 | -0.03 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.01 | -0.03 | -0.04 | Upgrade
|
| Free Cash Flow | -0.8 | -1.35 | -1.47 | -1.69 | -3.22 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.03 | Upgrade
|
| Gross Margin | 34.90% | 29.22% | -7.53% | -176.91% | 94.58% | Upgrade
|
| Operating Margin | -193.70% | -477.44% | -696.79% | -1289.55% | -6251.53% | Upgrade
|
| Profit Margin | -243.64% | -567.30% | -623.44% | -3709.64% | -7487.51% | Upgrade
|
| Free Cash Flow Margin | -169.03% | -470.00% | -623.72% | -1217.90% | -4883.95% | Upgrade
|
| EBITDA | -0.81 | -1.23 | -1.35 | -1.08 | -3.57 | Upgrade
|
| EBITDA Margin | -171.38% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.11 | 0.15 | 0.29 | 0.7 | 0.55 | Upgrade
|
| EBIT | -0.91 | -1.38 | -1.64 | -1.79 | -4.12 | Upgrade
|
| EBIT Margin | -193.70% | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.